Search Results - "Rosamilia, Marianne"

Pharmacokinetics and Pharmacodynamics of Imatinib in a Phase I Trial With Chronic Myeloid Leukemia Patients by Peng, Bin, Hayes, Michael, Resta, Debra, Racine-Poon, Amy, Druker, Brian J, Talpaz, Moshe, Sawyers, Charles L, Rosamilia, Marianne, Ford, John, Lloyd, Peter, Capdeville, Renaud

“…To evaluate the basic pharmacokinetic (PK) characteristics of imatinib mesylate and assess the relationship between the PK and pharmacodynamic (PD) properties…”
Get full text

An international expanded-access programme of everolimus: Addressing safety and efficacy in patients with metastatic renal cell carcinoma who progress after initial vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapy by Grünwald, Viktor, Karakiewicz, Pierre I, Bavbek, Sevil E, Miller, Kurt, Machiels, Jean-Pascal, Lee, Se-Hoon, Larkin, James, Bono, Petri, Rha, Sun Young, Castellano, Daniel, Blank, Christian U, Knox, Jennifer J, Hawkins, Robert, Anak, Oezlem, Rosamilia, Marianne, Booth, Jocelyn, Pirotta, Nicoletta, Bodrogi, István

“…Abstract Background and objectives The RECORD-1 trial established the clinical benefit of everolimus in patients with metastatic renal cell carcinoma (mRCC)…”
Get full text

Imatinib mesylate (STI571) for treatment of children with Philadelphia chromosome-positive leukemia: results from a Children's Oncology Group phase 1 study by Champagne, Martin A., Capdeville, Renaud, Krailo, Mark, Qu, Wenchun, Peng, Bin, Rosamilia, Marianne, Therrien, Martine, Zoellner, Ulrike, Blaney, Susan M., Bernstein, Mark

“…The purpose of this study was to determine dose-limiting toxicities and pharmacokinetics of imatinib in children with refractory or recurrent Philadelphia…”
Get full text